semaglutide novo nordisk asks FDA to prevent compounders from making GLP-1 knockoffs Article » PBD

Itchy skin is not listed as a common side effect of semaglutide in clinical trials, but some patients report skin sensations during treatment

Boehringer Ingelheim and Gubra initiate Phase 1 trials for BI 3034701, a novel triple-agonist peptide drug candidate for obesity.

In 2024, we also saw unprecedented willingness by large numbers of patients to pay out of pocket, even in European markets, as public coverage of AOMs is still limited, at best, and more often non-existent

In Pakistan, patients typically spend 1,500/ & 2,100 (.., 70/30 )

Results Four head-to-head randomized controlled studies with 1755 patients were included